Brain Scientific Stock Price To Sales
BRSF Stock | USD 0.75 0.00 0.00% |
Brain Scientific fundamentals help investors to digest information that contributes to Brain Scientific's financial success or failures. It also enables traders to predict the movement of Brain Pink Sheet. The fundamental analysis module provides a way to measure Brain Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Brain Scientific pink sheet.
Brain |
Brain Scientific Company Price To Sales Analysis
Brain Scientific's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Brain Scientific Price To Sales | 26.56 X |
Most of Brain Scientific's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Brain Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition |
Based on the latest financial disclosure, Brain Scientific has a Price To Sales of 26.5593 times. This is 24.11% higher than that of the Healthcare sector and notably higher than that of the Medical Devices industry. The price to sales for all United States stocks is 132.57% lower than that of the firm.
Brain Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Brain Scientific's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Brain Scientific could also be used in its relative valuation, which is a method of valuing Brain Scientific by comparing valuation metrics of similar companies.Brain Scientific is currently under evaluation in price to sales category among its peers.
Brain Fundamentals
Return On Equity | -45.97 | |||
Return On Asset | -1.17 | |||
Operating Margin | (28.77) % | |||
Current Valuation | 12.28 M | |||
Shares Outstanding | 105.4 M | |||
Shares Owned By Insiders | 23.83 % | |||
Shares Owned By Institutions | 18.54 % | |||
Price To Sales | 26.56 X | |||
Revenue | 265.75 K | |||
Gross Profit | 83.23 K | |||
EBITDA | (8.32 M) | |||
Net Income | (9.1 M) | |||
Cash And Equivalents | 3.54 M | |||
Cash Per Share | 0.03 X | |||
Total Debt | 9.97 M | |||
Debt To Equity | 0.18 % | |||
Current Ratio | 0.59 X | |||
Book Value Per Share | 0.07 X | |||
Cash Flow From Operations | (5.87 M) | |||
Earnings Per Share | (0.29) X | |||
Number Of Employees | 28 | |||
Beta | -0.88 | |||
Market Capitalization | 316.21 M | |||
Total Asset | 13.38 M | |||
Z Score | 18.6 | |||
Net Asset | 13.38 M |
About Brain Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Brain Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brain Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brain Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
IBTA | Ibotta, | |
DTST | Data Storage Corp | |
ESRT | Empire State Realty | |
IBTA | Ibotta, | |
GTES | Gates Industrial |
Other Information on Investing in Brain Pink Sheet
Brain Scientific financial ratios help investors to determine whether Brain Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brain with respect to the benefits of owning Brain Scientific security.